Vermillion Investor Seeks Court Order to Force Company to Schedule Annual Shareholder Meeting | GenomeWeb

Vermillion shareholder George Bessenyei this week brought an action against the company in the Delaware Court of Chancery to force it to hold its annual shareholder meeting.

In the action, Bessenyei notes that Vermillion's last shareholder meeting was in June 2011 and asserts that the company is in violation of Section 211 of Delaware's General Corporation Law, which establishes the rules for corporate stockholder meetings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.